• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
CFI-400945

CFI-400945

Product ID C211324
Cas No. 1338806-73-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $102.30 In stock
5 mg $204.40 In stock
25 mg $511.10 In stock
100 mg $1,465.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

CFI-400945 is an inhibitor of polo-like kinase 4 (PLK4). PLK4 plays an important role in centriole replication, and inhibition of PLK4 disrupts mitosis. CFI-400945 inhibits tumor growth in models of pancreatic cancer. PLK4 inhibition may be effective against osteosarcoma, where it is theorized that overexpression of PLK4 may be a driving force in osteosarcoma development and preservation.

Product Info

Cas No.

1338806-73-7

Purity

≥98%

Formula

C33H34N4O3

Formula Wt.

534.66

Chemical Name

(1R,2S)-2-{3-[(E)-2-(4-{[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl}phenyl)vinyl]-1H-indazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'H)-one

IUPAC Name

(1R,2S)-2-{3-[(E)-2-(4-{[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl}phenyl)vinyl]-1H-indazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'H)-one

Synonym

CFI 400945, CFI400945, CFI-400945 (free base)

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

C211324 MSDS PDF

Info Sheet

C211324 Info Sheet PDF

References

Lohse I., Mason J., et al. Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. Oncotarget. 8(2):3064-71 (2017). PMID: 27902970.

Kelleher F., Kores J., et al. Targeting the centrosome and polo-like kinase 4 in osteosarcoma. Carcinogenesis. 40(4):493-99 (2019). PMID: 30508038.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C6935

    Crizotinib

    ALK, ROS1, c-MET inhibitor.

    ≥98%
  • P0254

    Panaxatriol

    Triterpene sapogenin found in species of Panax;...

    ≥98%
  • O1200

    Odanacatib

    Cathepsin K inhibitor.

    ≥99%
  • L0248

    Laminin Peptide YIGSR

    Laminin-derived peptapeptide.

    ≥98%
  • A7578

    Astragaloside IV

    Found in Astragalus membranaceus.

    ≥98%
  • A0933

    Acitretin

    Retinoid; RARα/β/γ agonist.

    ≥98%, multiple isomers
  • R3197

    Rhynchophylline

    Oxyindole alkaloid found in Uncaria sinensis; h...

    ≥98%
  • X0384

    XAV-939

    Tankyrase inhibitor.

    ≥98%
  • T1849

    Temozolomide

    Imidazotetrazine, DNA alkylator.

    ≥98%
  • C2816

    Cheirolin

    Naturally produced ITC, sulfonyl analog of sulf...

    ≥97%
  • N582686

    L-(-)-Norepinephrine-(+)-bitartrate

    Endogenous hormone and neurotransmitter involve...

    ≥98%
  • N1858

    Neosolaniol

    Type A trichothecene mycotoxin produced by Fusa...

    ≥98%
  • F3205

    Fibrinogen γ-chain Dodecapeptide

    Platelet substitute, peptide; GP IIb/IIIa activ...

    ≥95%
  • D3372

    Disodium Cycloheptylaminomethylene Diphosphate

    Bisphosphonate; squalene synthase inhibitor.

    ≥98%
  • N859610

    NVP-HDM201

    HDM2 inhibitor

    ≥99%
  • P1202

    PD-325901

    MEK1/2 and Raf inhibitor.

    ≥99%
  • T5869

    Torcetrapib

    Cholesterol ester transfer protein inhibitor.

    ≥98%
  • T5720

    Tofacitinib Citrate

    JAK1/2/3 inhibitor.

    ≥99%
  • R2514

    RGDV

    Tretraeptide, binds cell surface integrins.

    ≥98%
  • G1308

    GDC-0032

    PI3K inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only